This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchovsky, A. S.
Right arrow Articles by Leguizamon, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchovsky, A. S.
Right arrow Articles by Leguizamon, M. S.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2001, p. 187-189, Vol. 8, No. 1
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.1.187-189.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

trans-Sialidase Inhibition Assay, a Highly Sensitive and Specific Diagnostic Test for Chagas' Disease

A. S. Buchovsky,1 O. Campetella,2 G. Russomando,3 L. Franco,3 R. Oddone,3 N. Candia,3 A. Luquetti,4 S. M. Gonzalez Cappa,1 and M. S. Leguizamon1,*

Departamento de Microbiología, Facultad de Medicina, Universidad de Buenos Aires,1 and Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martin,2 Buenos Aires, Argentina; Instituto de Ciencias de la Salud, Universidad Nacional de Asunción, Paraguay3; and Instituto de Patologia Tropical e Saude Publica, Universidad Federal de Goias, Goiania, Brazil4

Received 9 June 2000/Returned for modification 28 July 2000/Accepted 9 October 2000

For the diagnosis of Chagas' disease, the trans-sialidase inhibition assay was able to resolve the results for samples with borderline results, to detect as positive 60% of samples that were negative by conventional serology, and to discriminate idiopathic from chagasic megaviscera or cardiopathy. No cross-reaction with sera from patients with other diseases was observed.

* Corresponding author. Mailing address: Departamento de Microbiologia, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155 Piso 13, 1121 Buenos Aires, Argentina. Phone and Fax: 54-11-4963-7078. E-mail: sleguiza{at}fmed.uba.ar.

Clinical and Diagnostic Laboratory Immunology, January 2001, p. 187-189, Vol. 8, No. 1
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.1.187-189.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Pereira-Chioccola, V. L., Fragata-Filho, A. A., Levy, A. M. d. A., Rodrigues, M. M., Schenkman, S. (2003). Enzyme-Linked Immunoassay Using Recombinant trans-Sialidase of Trypanosoma cruzi Can Be Employed for Monitoring of Patients with Chagas' Disease after Drug Treatment. CVI 10: 826-830 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»